Product Information

TOPIRAMATE 25 MG/ML SOLUTION is a generic product labeled by Ascend Laboratories, LLC, priced at $2.1184 per ML under NDC 67877083361. Its NADAC has been published 27 times since Feb 18, 2026.

FDA first approved this application on Oct 31, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE 25 MG/ML SOLUTION

TOPIRAMATE
$2.1184per ML

Strength

25 mg/mL

NDC

67877083361

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA217795

FDA Approved

10/31/2024

TE Code

AB

On Market Since

7/7/2025

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE 25 MG/ML SOLUTION has been published 27 times since Feb 18, 2026, and over the history we have for it it has risen 11.1%. The table below summarizes its recorded NADAC range and movement.

Current price$2.1184 per ML
All-time high$2.1184 (Aug 19, 2026)
All-time low$1.9059 (Feb 18, 2026)
52-week high$2.1184
52-week low$1.9059
Median price$2.0030
Average price$2.0010
Largest weekly change+3.5% (Jun 17, 2026)
Weeks tracked27
Tracking sinceFeb 18, 2026

Price History

1W

+0.9%

1M

+2.1%

3M

+5.8%

6M

+11.1%

1Y

N/A

3Y

N/A

5Y

N/A

All

+11.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 49%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of TOPIRAMATE 25 MG/ML SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 25 MG/ML SOLUTION, manufactured by Ascend Laboratories, LLC, is $2.1184 per ML (NDC 67877083361), effective Aug 19, 2026.

How has the price of TOPIRAMATE 25 MG/ML SOLUTION changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE 25 MG/ML SOLUTION has risen 11.1%. It has been tracked across 27 weekly CMS publications since Feb 18, 2026.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE 25 MG/ML SOLUTION?

Since Feb 18, 2026, the NADAC for TOPIRAMATE 25 MG/ML SOLUTION has ranged from a low of $1.9059 (Feb 18, 2026) to a high of $2.1184 (Aug 19, 2026), with a median of $2.0030 per ML.

Are there cheaper alternatives to TOPIRAMATE 25 MG/ML SOLUTION?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE 25 MG/ML SOLUTION, is $1.0826 per ML — about 49% below TOPIRAMATE 25 MG/ML SOLUTION.

Who manufactures TOPIRAMATE 25 MG/ML SOLUTION?

TOPIRAMATE 25 MG/ML SOLUTION (NDC 67877083361) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.